0431, MK,
4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-amine,
Anhydrous, Sitagliptin Phosphate,
Januvia,
MK 0431,
MK-0431,
MK0431,
Monohydrate, Sitagliptin Monophosphate,
Monohydrate, Sitagliptin Phosphate,
Monophosphate Monohydrate, Sitagliptin,
Phosphate Anhydrous, Sitagliptin,
Phosphate Monohydrate, Sitagliptin,
Phosphate, Sitagliptin,
sitagliptin,
sitagliptin monophosphate monohydrate,
sitagliptin phosphate,
sitagliptin phosphate anhydrous,
sitagliptin phosphate monohydrate,
Sitagliptin phosphate monohydrate,
654671-77-9,
Sitagliptin phosphate,
Januvia,
UNII-TS63EW8X6F,
(R)-3-Amino-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one phosphate hydrate,
Sitagliptin phosphate hydrate,
Sitagliptin (phosphate monohydrate),
TS63EW8X6F,
Sitagliptin phosphate [USAN],
MK-0431,
Tesavel,
MFCD10001393,
Sitagliptin phosphate (USAN),
Glactiv,
(3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one;phosphoric acid;hydrate,
AK126749,
Januvia (TN),
PubChem18266,
SCHEMBL1039535,
CHEMBL1201174,
KS-00000FHI,
GQPYTJVDPQTBQC-KLQYNRQASA-N,
AOB87362,
ONO-5435,
sitagliptin monophosphate monohydrate,
Sitagliptin phosphate hydrate (JAN),
GP3542,
HY-13749B,
MK-431,
s4002,
C16H15F6N5O.H2O.H3O4P,
AKOS015895530,
AC-1939,
AN-1039,
CCG-213562,
CS-3683,
RL04491,
AS-18643,
BC677054,
AB0028055,
AX8110160,
FT-0649098,
ST24035442,
X0051,
D06645,
671S779,
I06-1070,
(2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine dihydrogenphosphate monohydrate,
(2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-alpha]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine dihydrogenphosphate monohydrate,
(3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one; phosphoric acid; hydrate,
(R)-3-Amino-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one phosphate hydra,
1,2,4-Triazolo(4,3-a)pyrazine, 7-((3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl)-5,6,7,8- tetrahydro-3-(trifluoromethyl)-, phosphate (1:1) monohydrate,
1,2,4-Triazolo[4,3-a]pyrazine,7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-, phosphate (1:1), monohydrate,
7-((3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(trifluoromethyl)-5,6,7,8-tetrahydro-1,2,4- triazolo(4,3-a)pyrazine monophosphate monohydrate,
7-(3R)-3-Amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl-5,6,7,8-tetrahydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazine phosphate hydrate,
Sitagliptin,
Xelevia,
Sitagliptin monohydrate,
cc-318,
Sitagliptin phosphate [USAN:INN],
ACN-028817,
CID11591741,
2201H,
A10848,
Sitagliptin phosphate monohydrate, 97%, DPP-IV inhibitor - 1G 1g,
486460-32-6,